Editor – We appreciate the RCP concise guideline on fibromyalgia (FMS),1 but are disappointed attention deficit hyperactivity disorder (ADHD) is not mentioned. Anxiety and depression are mentioned but these may be merely symptoms secondary to underlying disorders (eg post-traumatic stress disorder, ADHD, autism), and we risk oversimplifying the psychological part of the biopsychosocial model. Several studies show that ADHD (either formally diagnosed or implied by positive screening tests) is prevalent in patients with FMS: 44.7% in a South African study,2 24.5% in an Italian study,3 32.3% in a Spanish study,4 25% in a study undertaken in the Netherlands,5 and 29.5% in a Turkish study.6 Symptoms of ADHD correlate with severity of FMS.7 Bou Khalil et al8 suggest how the psychopathology of ADHD may predispose to FMS. Patients with suspected but unconfirmed FMS may be likely to have similar rates of ADHD.
As early as 1998, Krause et al9 noticed that some patients with ADHD had FMS and that treatment with stimulants could help both conditions. Despite the absence of randomised controlled trial evidence, it remains likely that treating comorbid ADHD improves quality of life, if not FMS directly. It is interesting to note10 that methylphenidate improves tolerability of pain in ADHD (without FMS). The RCP guidelines are aimed at generalists, who are responsible for referring to mental health services: it would be important not to miss a common treatable comorbidity. FMS may also be associated with prior PTSD11 and autism,12 which may benefit also from specific interventions.
Physicians, and commissioners, may note that ADHD is common in other 'physical’ conditions,13 particularly chronic fatigue syndrome, and hypermobility spectrum disorders, which are also associated with FMS. Further, physicians may be interested to know that ADHD is associated with autonomic dysfunction such as postural orthostatic tachycardia syndrome (POTS), functional bowel disorders, functional urinary disorders such as enuresis, migraine, and other conditions.
Competing interests
Drs Leaver & Parry are affiliated with the UK Adult ADHD Network (UKAAN).
References
- 1.guideline development group. Berwick R, Barker C, Goebel A. The diagnosis of fibromyalgia syndrome. Clin Med. 2022;22:570–574. doi: 10.7861/clinmed.2022-0402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.van Rensburg R, Meyer HP, Hitchcock SA, Schuler CE. Screening for adult ADHD in patients with fibromyalgia syndrome. Pain Med. 2018;19:1825–1831. doi: 10.1093/pm/pnx275. [DOI] [PubMed] [Google Scholar]
- 3.Pallanti S, Porta F, Salerno L. Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities. J Psychiatr Res. 2021;136:537–542. doi: 10.1016/j.jpsychires.2020.10.027. [DOI] [PubMed] [Google Scholar]
- 4.Reyero F, Ponce G, Rodriguez-Jimenez R, et al. High frequency of childhood ADHD history in women with fibromyalgia. Eur Psychiatry. 2011;26:482–483. doi: 10.1016/j.eurpsy.2010.03.012. [DOI] [PubMed] [Google Scholar]
- 5.Derksen MT, Vreeling MJ, Tchetverikov I. High frequency of adult attention deficit hyperactivity disorder among fibromyalgia patients in the Netherlands: should a systematic collaboration between rheumatologists and psychiatrists be sought? Clin Exp Rheumatol. 2015;33:S141. [PubMed] [Google Scholar]
- 6.Yılmaz E, Tamam L. Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatr Dis Treat. 2018;14:1883–1889. doi: 10.2147/NDT.S159312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Türkoğlu G. Attention-deficit hyperactivity disorder symptoms and quality of life in female patients with fibromyalgia. Turk J Med Sci. 2021;51:1747–1755. doi: 10.3906/sag-2010-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bou Khalil R, Khoury E, Richa S. The comorbidity of fibromyalgia syndrome and attention deficit and hyperactivity disorder from a pathogenic perspective. Pain Med. 2018;19:1705–1709. doi: 10.1093/pm/pny142. [DOI] [PubMed] [Google Scholar]
- 9.Krause K-H, Krause J, Magyarosy I, et al. Fibromyalgia syndrome and attention deficit hyperactivity disorder: is there a comorbidity and are there consequences for the therapy of fibromyalgia syndrome? J Musculoskelet Pain. 1998;6:111–116. [Google Scholar]
- 10.Treister R, Eisenberg E, Demeter N, Pud D. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD) Pain Pract. 2015;15:4–11. doi: 10.1111/papr.12129. [DOI] [PubMed] [Google Scholar]
- 11.Häuser W, Galek A, Erbslöh-Möller B, et al. Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. Pain. 2013;154:1216–1223. doi: 10.1016/j.pain.2013.03.034. [DOI] [PubMed] [Google Scholar]
- 12.Miyamae T, Chiba Y, Kato I, Tani Y, Yamanaka H. Neurodevelopmental disorders associated with juvenile fibromyalgia. Pediatr Int. 2018;60:1034–1035. doi: 10.1111/ped.13696. [DOI] [PubMed] [Google Scholar]
- 13.Instanes JT, Klungsøyr K, Halmøy A, Fasmer OB, Haavik J. Adult ADHD and comorbid somatic disease: a systematic literature review. J Atten Disord. 2018;22:203–228. doi: 10.1177/1087054716669589. [DOI] [PMC free article] [PubMed] [Google Scholar]